Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
スポンサーリンク
概要
- 論文の詳細を見る
- 2002-01-01
著者
-
Yoshida H
National Hospital Organization Nagasaki Medical Center
-
IDE Tatsuya
Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine
-
MORITA Yasuyo
Nagata Hospital
-
Morita Yasuyo
The Second Department Of Medicine Kurume University School Of Medicine
-
Ide Tatsuya
久留米大学 医学部免疫学講座
-
Ide T
Department Of Second Internal Medicine Kurume University School Of Medicine
-
Ide Tatsuya
Second Department Of Internal Medicine Kurume University School Of Medicine
-
Ide Tatsuya
久留米大学 医学部内科学第二
-
Sakata M
Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine
-
Sata Michio
久留米大学 大学院医学研究科消化器疾患情報講座
-
Sata Michio
京都府立医科大学 消化器内科学
-
TANAKA Eiji
Shinsyu University Graduate School of Medicine
-
HINO Teruko
The Second Department of Medicine, Division of Kidney Disease and Critical Care Medicine, Kurume Uni
-
SATA Michio
The Second Department of Medicine, Division of Kidney Disease and Critical Care Medicine, Kurume Uni
-
YOSHIDA Hiroshi
Second Department of Medicine, Kurume University School of Medicine
-
Sakamoto Masaharu
Second Department Of Medicine Kurume University School Of Medicine
-
Okita Kiwamu
下関厚生病院(社保)
-
Tahara Kenji
Department Of Internal Medicine Kagoshima Kouseiren Hospital
-
Tanikawa K
Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine
-
Kumashiro Ryukichi
The Second Department Of Medicine Division Of Kidney Disease And Critical Care Medicine Kurume Unive
-
Taniguchi E
Department Of Medicine Kurume University School Of Medicine
-
Taniguchi Eitaro
Second Department Of Medicine Kurume University School Of Medicine
-
Ide Tatsuya
久留米大学 医学部消化器内科
-
Ide Tatsuya
Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine
-
Ide Tatsuya
The Second Department Of Medicine Kurume University School Of Medicine
-
Ide Tatsuya
2nd Department Of Internal Medicine Kurume University School Of Medicine
-
Ide Tatsuya
Kurume Univ. School Of Medicine Fukuoka Jpn
-
Kawaguchi Takumi
久留米大学 大学院医学研究科消化器疾患情報講座
-
Ohkawa Kazuyoshi
大阪大学
-
TANIKAWA Kyuichi
International Institute for Liver Research
-
Ogata Kei
The Second Department Of Medicine Division Of Kidney Disease And Critical Care Medicine Kurume Unive
-
Sata Michio
久留米大学 医学部免疫学講座
-
Sata Michio
久留米大学 消化器内科
-
Ide T
Second Department Of Internal Medicine Kurume University School Of Medicine
-
Iwao Tadashi
Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine
-
Hino Teruko
The Second Department Of Medicine Division Of Kidney Disease And Critical Care Medicine Kurume Unive
-
MURASHIMA Shiro
The Second Department of Medicine, Kurume University School of Medicine
-
Tanikawa Kyuichi
Second Department Of Medicine Division Of Gastroenterology And Endoscopy Kurume University School Of
-
SASAKI Masaru
The Second Department of Medicine, Kurume University School of Medicine
-
SUZUKI Hiroshi
The Second Department of Medicine, Kurume University School of Medicine
-
MIYAJIMA Ichiro
The Second Department of Medicine, Kurume University School of Medicine
-
TANAKA Eisuke
The Second Department of Medicine, Kurume University School of Medicine
-
YOSHIDA Hiroshi
Internal Medicine, Yame General Public Hospital
-
Murashima S
Second Department Of Internal Medicine Kurume University School Of Medicine
-
Okita Kiwamu
Department Of Gastroenterology And Hepatology Yamaguchi University Graduate School Of Medicine
-
Okita K
Yamaguchi Univ. Yamaguchi Jpn
-
Ogata Kei
Second Department Of Internal Medicine Kurume University School Of Medicine
-
Omori Kaoru
Department Of Molecular Science & Applied Medicine (gastroenterology & Hepatology) Yamaguchi
-
Yoshida H
Department Of Internal Medicine Division Of Gastroenterology And Hepatology St. Marianna University
-
Yotsuyanagi Hiroshi
National Hospital Organization Nagasaki Medical Center
-
MIYAZIMA Ichiro
the Second Department of Medicine
-
Ide Tatsuya
The Second Department Of Medicine Division Of Kidney Disease And Critical Care Medicine Kurume Unive
-
Taniguchi Eitaro
Department Of Medicine Kurume University School Of Medicine
-
Sata Michio
The Second Department Of Medicine Research Center For Innovative Cancer Therapy
-
Suzuki H
Yamanashi University
-
Miyajima I
The Second Department Of Medicine Kurume University School Of Medicine
-
Tanikawa K
Kurume Univ. Kurume
-
Tanaka Eisuke
The Second Department Of Medicine Kurume University School Of Medicine
-
Tanaka Eisuke
Hepato-gastroenterology Unit Clinical Research Institute National Kyushu Medical Center Hopital
-
Tanaka E
Shinsyu University Graduate School Of Medicine
-
Sata Michio
Second Dep. Of Internal Medicine Kurume Univ. School Of Medicine
-
Murashima Shiroh
Second Department Of Internal Medicine Kurume University School Of Medicine
-
Tanaka Eisuke
Shinsyu University Graduate School Of Medicine
-
Kawaguchi Takumi
Department Of Digestive Disease Information & Research Kurume University School Of Medicine
-
Miyajima Ichiro
The Second Department Of Medicine Kurume University School Of Medicine
-
Yoshida Hiroshi
Department Of Infectious Disease University Of Tokyo
-
Yotsuyanagi Hiroshi
Department Of Infectious Diseases University Of Tokyo
-
Ide Tatsuya
Department Of Second Internal Medicine Kurume University School Of Medicine
-
Okita Kiwamu
Department Of Molecular Science & Applied Medicine (gastroenterology & Hepatology) Yamaguchi
-
Saito Hiroshi
Yamanashi University
-
SATA Michio
the Second Department of Internal Medicine, Kurume University of Medicine
-
HINO Teruko
the Second Department of Internal Medicine, Kurume University of Medicine
-
KUMASHIRO Ryukichi
the Second Department of Internal Medicine, Kurume University of Medicine
-
TANIKAWA KYUICHI
International Hepatology Research Institute
関連論文
- Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease
- Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan
- Human primary cultured hepatic stellate cells can be cryopreserved
- High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma
- Case-control study for the identification of virological factors associated with fulminant hepatitis B
- Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients
- Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis
- Periostin and bone marrow fibrosis
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- Keratin inclusions alter cytosolic protein localization in hepatocytes
- Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load
- Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
- Impaired Filterability of Erythrocytes from Patients with Chronic Hepatitis C and Effects of Eicosapentaenoic Acid on the Filterability
- New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
- Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report
- Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
- Liposome-mediated gene transfer of K1-5 suppresses tumor development and improves the prognosis of hepatocellular carcinoma in mice
- A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C
- Angiogenic cell therapy for hepatic fibrosis
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment
- A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis
- Combination chemotherapy with cisplatin and gemcitabine in malignant peritoneal mesothelioma
- Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil
- Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
- Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
- Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
- Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
- Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
- Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
- Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
- A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
- Unusual hyperbilirubinemia associated with bacterial pneumonia and acute myeloid leukemia
- Blastoid Variant of Mantle Cell Lymphoma with Lactic Acidosis : A Case Report
- Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases
- Effect of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis C virus infection
- Impaired Gastric Motility in Patients with Functional Dyspepsia
- Improvement of gastric motility by hemodialysis in patients with chronic renal failure
- Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C
- Bronchiolitis obliterans organizing pneumonia in a patient with primary biliary cirrhosis and rheumatoid arthritis treated with prednisolone
- High prevalence of anticardiolipin antibodies in hepatitis C virus infection : lack of effects on thrombocytopenia and thrombotic complications
- Systemic Sclerosis Associated with Diabetes Insipidus
- Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
- ENDOSCOPIC RETRIEVAL OF MIGRATED PLASTIC STENT INTO BILE DUCT OR PANCREATIC PSEUDOCYST
- Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
- Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon
- GB virus C (GBV-C)/hepatitis G virus (HGV) infection in a hepatitis C virus hyper-endemic area in Japan
- Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene
- Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
- OVEREXPRESSION OF MEMBRANE-TYPE 1 MATRIX METALLOPROTEINASE (MT1-MMP), MATRIX METALLOPRATEINASE-2 (MMP-2) IS ASSOCIATED WITH TUMOR DEVELOPMENT IN HEPATOCELLULAR CARCINOMA (HCC).
- ANTI-TGF-β INTERVENTION INHIBITS PROGRESSION OF HEPATIC FIBROSIS
- RHO SIGNALING IS REQUIRED FOR MECHANICAL STRETCH-INDUCED TGF-β PRODUCTION IN HEPATIC STELLATE CELLS
- CHANGES OF CELL, EXTRACELLULAR MATRIX, APOPTOSIS AND ANGlOGENESIS IN HEPATIC INJURY AND REPAIR
- Two-year follow-up study after treatment with lamivudine for chronic hepatitis B : seven cases reported
- Erythropoietic protoporphyria with fatal liver failure
- Antiphospholipid syndrome modifies the clinical features of systemic lupus erythematosus
- Antibody Reactive to a Hepatitis C Virus (HCV)-Derived Peptide Capable of Inducing HLA-A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV-Infected Individuals without HLA-A2 Restriction
- Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5-Aza-2'-deoxycytidine
- Involvement of GBV-C/HGV in liver diseases in Japan
- High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
- Lack of detection of hepatitis C virus replicative intermediate in abdominal lymph nodes
- Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels
- Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine
- Dextromethorphan for neuropathic pain with Churg-Strauss syndrome
- Polyarteritis nodosa with mesenteric aneurysms demonstrated by angiography : report of a case and successful treatment of the patient with prednisolone and cyclophosphamide
- Pulse Intravenous Cyclophosphamide Treatment for Steroid-resistant Interstitial Pneumonitis Associated with Polymyositis
- Sero-epidemiologic study of hepatitis C virus infection in Fukuoka, Japan
- Serological Study of Bartonella henselae in Cat Scratch Disease in Japan
- Relapsing Polychondritis Associated with Subclinical Sjogre's Syndrome and Phlegmon of the Neck
- Effects of OK-432 on matrix metalloproteinase-9 expression and activity in rat cultured Kupffer cells
- Clinical usefulness of serum HBV DNA measurement with a non radioactive chemiluminescence method
- A pilot study of natural interferon γ therapy for chronic hepatitis C
- Liver-Associated Natural Killer Activity in Cirrhotic Rats
- Characteristics of complete responders to interferon among patients with chronic hepatitis C with high serum levels of RNA
- Controlled release of simvastatin acid using cyclodextrin inclusion system
- Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B
- Protonation-Induced Conformational Changes of N,N,N',N'-Tetramethylethylenediamine. Importance of Strong N-H^+…N Hydrogen Bonding
- Conformational Order of the Alkyl Chain in a Nonionic Surfactant α-Dodecyl-ω-hydroxytris (oxyethylene) (C_E_3) in Water
- Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
- Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
- Second generation amplicor-HCV monitor assay : clinical features and predictors of the response to interferon
- Gender difference in alcoholic liver desease in Japan-an analysis based on histological findings
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
- A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis
- Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan
- ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C
- Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C
- Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
- GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION)
- Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
- Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD : a pilot study
- Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
- The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
- Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
- Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection : decision-tree analysis
- Effect of Varying Polymerization Modes on Flexural Strength of an Indirect Composite Reinforced with a Monomer-Impregnated Glass Fiber Material
- Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1
- Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy
- The Importance of a Prior Psychiatric Examination in Pegylated Interferon and Ribavirin Combination Treatment for Chronic Hepatitis C